Bixiye
bc-com-pharmprogpolicynotifctn-eff-7.1.23.pdf
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1281 - 1290 ee natiijooyinka 3563
Bixiye
QP36-23 Eligibility Redeterminations for Minnesota Health Care Programs Members
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP37-23 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP38-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2023
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP39-23 Commercial Pharmacy Benefit Exclusion for Lamzede®
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP40-23 MHCP Pharmacy Benefit Exclusion for Lamzede® and Zynyz™
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP41-23 Makena® (hydroxyprogesterone caproate): Drug Approval Withdrawn
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP42-23 FreeStyle Libre, Libre 14 day, and Libre 2 Flash: Medical Device Correction
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023
Bixiye
QP43-23 Minnesota Health Care Programs (MSHO) Model of Care Annual Training Requirement Reminder
Taariikhda uu dhaqangalayo Barnaamijka: May 10, 2023